Cargando…
Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis
BACKGROUND: Multi drug-resistant and mycobacterial infections are a major public health challenge, leading to high mortality and socioeconomic burdens through worldwide. Novel therapeutics are necessary to treat the drug resistant strains, since no new chemical entities are emerged in the last four...
Autores principales: | Anguru, Mohana Rao, Taduri, Ashok Kumar, Bhoomireddy, Rama Devi, Jojula, Malathi, Gunda, Shravan Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524660/ https://www.ncbi.nlm.nih.gov/pubmed/29086847 http://dx.doi.org/10.1186/s13065-017-0295-z |
Ejemplares similares
-
A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
por: Chatla, Chakrapani, et al.
Publicado: (2021) -
Chemical Synthesis of Cell Wall Constituents of Mycobacterium tuberculosis
por: Holzheimer, Mira, et al.
Publicado: (2021) -
Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis
por: Kuang, Wenbin, et al.
Publicado: (2022) -
Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019) -
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling
por: Li, Michael, et al.
Publicado: (2022)